ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Characterizing technical success and clinical outcomes in patients with pulmonary embolism treated with ultrasound-assisted catheter-directed thrombolysis (USAT): a retrospective, single-center cohort study.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in thoracic ultrasound.The European respiratory journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUltrasound-assisted catheter-directed thrombolysis (USAT) is a treatment option for patients with intermediate-high- or high-risk pulmonary embolism (PE). This study aimed to describe the use of USAT and its clinical outcomes.
methodsIn this single-center retrospective cohort study, all USAT procedures performed between May 2019 and June 2022 were included. Data were collected from electronic health records. The primary outcome was reduction in right vs. left ventricular diameter (RV/LV ratio). Secondary outcomes were in-hospital mortality and bleeding.
resultsA total of 107 patients underwent USAT for PE. The median age was 64 (IQR 53-75) years and 59% were male. Technical success of USAT was achieved in 105 (98%) cases. In 32 cases data on RV/LV ratio changes were available. RV/LV ratio decreased by 0.29 ± 0.19 from 1.19 (1.02-1.35) to 0.89 (0.78-1.00). 12 (11%) patients had a fatal outcome. Bleeding complications were observed in 28 (26%) patients, including 14 (13%) major bleedings and 0 (0%) fatal. Both, death and bleeding rates were significantly higher in high-risk patients.
conclusionWe observed a high technical success of USAT in patients with intermediate-high- and high-risk pulmonary embolism, along with a significant early reduction of RV/LV ratio following treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.